Literature DB >> 12026240

Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn.

Magda Lahorgue Nunes1, Fabiana Mugnol, Igor Bica, Renato Machado Fiori.   

Abstract

Pyridoxine dependency and congenital hypophosphatasia are unusual metabolic disorders. We report a female infant born from healthy consanguineous parents with shortening of limbs, detected during pregnancy by ultrasonography. Immediately after delivery, the baby was admitted to the neonatal intensive care unit because of respiratory distress. A bone radiograph showed hypomineralization of all bones, and serum alkaline phosphatase was very low (10 U/L). Within the first day of life, seizures (focal clonic and tonic) started. The seizures were refractory to phenobarbital and other antiepileptic drugs. The first electroencephalogram (EEG) showed a burst-suppression pattern. Pyridoxine was administered (50 mg/kg) and completely controlled the seizures. Antiepileptic drugs were discontinued, and a maintenance dose of pyridoxine (10 mg/day) was established. A postpyridoxine EEG revealed the disappearance of the burst-suppression pattern. The patient died at age 26 days. Pyridoxine-dependent seizures, when recognized early and treated, have a more favorable prognosis. However, hypophosphatasia detected at birth almost always has a lethal outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12026240     DOI: 10.1177/088307380201700314

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures.

Authors:  Dina Belachew; Traci Kazmerski; Ingrid Libman; Amy C Goldstein; Susan T Stevens; Stephanie Deward; Jerry Vockley; Mark A Sperling; Arcangela L Balest
Journal:  JIMD Rep       Date:  2013-03-12

Review 2.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

3.  Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

Authors:  Michael P Whyte; Cheryl Rockman-Greenberg; Keiichi Ozono; Richard Riese; Scott Moseley; Agustin Melian; David D Thompson; Nicholas Bishop; Christine Hofmann
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

Review 4.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

Review 5.  Pediatric neurotransmitter diseases.

Authors:  Phillip L Pearl; Denise D Wallis; K Michael Gibson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

6.  Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis.

Authors:  Thomas Cruz; Marie Gleizes; Stéphane Balayssac; Etienne Mornet; Grégory Marsal; José Luis Millán; Myriam Malet-Martino; Lionel G Nowak; Véronique Gilard; Caroline Fonta
Journal:  J Neurochem       Date:  2017-03       Impact factor: 5.372

7.  Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report.

Authors:  Hüseyin Demirbilek; Yasemin Alanay; Ayfer Alikaşifoğlu; Meral Topçu; Etienne Mornet; Nazlı Gönç; Alev Özön; Nurgün Kandemir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-03

8.  Pyridoxine-Responsive Seizures in Infantile Hypophosphatasia and a Novel Homozygous Mutation in ALPL Gene.

Authors:  Banu Güzel Nur; Gamze Çelmeli; Esra Manguoğlu; Erdoğan Soyucen; İffet Bircan; Ercan Mıhçı
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

Review 9.  Alkaline Phosphatase, an Unconventional Immune Protein.

Authors:  Bethany A Rader
Journal:  Front Immunol       Date:  2017-08-03       Impact factor: 7.561

10.  Burden of disease in pediatric patients with hypophosphatasia: results from the HPP Impact Patient Survey and the HPP Outcomes Study Telephone interview.

Authors:  Eric T Rush; Scott Moseley; Anna Petryk
Journal:  Orphanet J Rare Dis       Date:  2019-08-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.